Who owns Abivax SA F Sponsored ADR?
- Ticker: ABVX
- CUSIP Number: 00370m103
Tip: Access positions for across all investors
Analyze quarterly positions in Abivax SA F with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Abivax SA F stock
Who bought or sold Abivax SA F Sponsored ADR this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
TCG Crossover Management | 6.1M | $44M | 0% | Dec 2024 |
|
Deep Track Capital | 3.6M | $41M | -14% | Sep 2024 |
|
Cormorant Asset Management | 2.1M | $16M | 0% | Dec 2024 |
|
Dr. Jeffrey R. Jay, M.D. | 1.6M | $12M | -23% | Dec 2024 |
|
Franklin Resources | 1.5M | $11M | 11% | Dec 2024 |
|
Nantahala Capital Management | 1.4M | $11M | 46% | Dec 2024 |
|
VR Adviser | 1.3M | $9.9M | 0% | Dec 2024 |
|
Commodore Capital | 1.3M | $15M | 0% | Sep 2024 |
|
Blackstone Group | 937k | $6.9M | -38% | Dec 2024 |
|
Millennium Management | 931k | $6.8M | 44% | Dec 2024 |
|
Citadel Advisors | 856k | $6.3M | 83% | Dec 2024 |
|
Samsara BioCapital | 850k | $6.2M | 0% | Dec 2024 |
|
Caligan Partners | 752k | $5.5M | 100% | Dec 2024 |
|
Jpmorgan Chase & Co | 729k | $5.3M | 100% | Dec 2024 |
|
Saturn V Capital Management | 648k | $7.5M | 3% | Sep 2024 |
|
ADAR1 Capital Management | 522k | $6.0M | 1832% | Sep 2024 |
|
Morgan Stanley | 479k | $3.5M | -5% | Dec 2024 |
|
Silverarc Capital Management | 462k | $5.3M | 1% | Sep 2024 |
|
Standard Life Aberdeen | 424k | $3.1M | 34% | Dec 2024 |
|
Boothbay Fund Management | 407k | $3.0M | 100% | Dec 2024 |
|
Walleye Trading Advisors | 303k | $2.2M | 18% | Dec 2024 |
|
Kennedy Capital Management | 226k | $1.7M | 1% | Dec 2024 |
|
UBS Group | 175k | $1.3M | 25207% | Dec 2024 |
|
Soleus Capital Management | 125k | $915k | 0% | Dec 2024 |
|
Atika Capital Management | 104k | $761k | -9% | Dec 2024 |
|
Point72 Asset Management | 91k | $668k | -83% | Dec 2024 |
|
HighVista Strategies | 49k | $359k | 0% | Dec 2024 |
|
Woodline Partners | 48k | $352k | -41% | Dec 2024 |
|
Two Sigma Investments | 20k | $145k | 100% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 19k | $141k | 48% | Dec 2024 |
|
Geode Capital Management | 17k | $123k | 8% | Dec 2024 |
|
Stonepine Capital Management | 15k | $110k | 100% | Dec 2024 |
|
Guggenheim Capital, LLC Managers | 13k | $92k | 100% | Dec 2024 |
|
Ameriprise Financial | 12k | $85k | 100% | Dec 2024 |
|
HighTower Advisors | 10k | $73k | 0% | Dec 2024 |
|
Cubist Systematic Strategies | 7.6k | $55k | -54% | Dec 2024 |
|
Bank of America Corporation | 5.5k | $41k | 56% | Dec 2024 |
|
GAMMA Investing | 4.0k | $29k | 100% | Dec 2024 |
|
Barclays | 1.1k | $8.0k | 100% | Dec 2024 |
|
Rhumbline Advisers | 706.00 | $5.2k | 3% | Dec 2024 |
|
Financial Management Professionals | 100.00 | $732.000000 | 0% | Dec 2024 |
|
Royal Bank of Canada | 37.00 | $0 | 100% | Dec 2024 |
|
Advisor Group Holdings | 25.00 | $183.000000 | -22% | Dec 2024 |
|
Principal Securities | 10.00 | $73.000000 | 0% | Dec 2024 |
|
Who sold out of Abivax SA F?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Adage Capital Partners GP | Sep 2024 | 531k | $6.1M |
Henderson Group | Sep 2024 | 411k | $4.7M |
Rosalind Advisors | Sep 2024 | 140k | $1.6M |
Polar Securities | Sep 2024 | 35k | $403k |
Options Solutions | Jun 2024 | 35k | $459k |
Marshall Wace | Sep 2024 | 31k | $356k |
Caxton | Sep 2024 | 11k | $131k |
Sandia Investment Management | Jun 2024 | 7.5k | $99k |